Citations (47)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Huibing Li, Xin Jin, Mingyao Lai, Yongshi Li, Ruixing Li, Huihui Yang & Baoying Yang. (2023) Knockdown of circ_CLIP2 regulates the proliferation, metastasis and apoptosis of glioma cells through miR-641/EPHA3/STAT3 axis. Journal of Neurogenetics 37:3, pages 93-102.
Read now
Read now
Liuxiang Chu, Aiping Wang, Ling Ni, Xiuju Yan, Yina Song, Mingyu Zhao, Kaoxiang Sun, Hongjie Mu, Sha Liu, Zimei Wu & Chunyan Zhang. (2018) Nose-to-brain delivery of temozolomide-loaded PLGA nanoparticles functionalized with anti-EPHA3 for glioblastoma targeting. Drug Delivery 25:1, pages 1634-1641.
Read now
Read now
Articles from other publishers (45)
Chao Jiang, Youjun Liu, Weigong Zhao, Yimin Yang, Zhiwei Ren, Xiaohui Wang, Dingjun Hao, Heng Du & Si Yin. (2023) microRNA‐365 attenuated intervertebral disc degeneration through modulating nucleus pulposus cell apoptosis and extracellular matrix degradation by targeting EFNA3. Journal of Cellular and Molecular Medicine.
Crossref
Crossref
Elena B. Pasquale. (2023) Eph receptors and ephrins in cancer progression. Nature Reviews Cancer.
Crossref
Crossref
H. Matthew Berns, Dawn E. Watkins‐Chow, Sizhu Lu, Pakavarin Louphrasitthiphol, Tongwu Zhang, Kevin M. Brown, Pedro Moura‐Alves, Colin R. Goding & William J. Pavan. (2023)
Single‐cell profiling of
MC1R
‐inhibited melanocytes
. Pigment Cell & Melanoma Research.
Crossref
Crossref
Manon de Vries-Brilland, Nathalie Rioux-Leclercq, Maxime Meylan, Jonathan Dauvé, Christophe Passot, Elena Spirina-Menand, Ronan Flippot, Gaëlle Fromont, Gwenaelle Gravis, Lionnel Geoffrois, Christine Chevreau, Fréderic Rolland, Ellen Blanc, Félix Lefort, Alain Ravaud, Marine Gross-Goupil, Bernard Escudier, Sylvie Negrier & Laurence Albiges. (2023) Comprehensive analyses of immune tumor microenvironment in papillary renal cell carcinoma. Journal for ImmunoTherapy of Cancer 11:11, pages e006885.
Crossref
Crossref
Myung Woul Han. (2023) The Mechanisms and Overcoming Strategies of the Radioresistance in Head and Neck Cancer. Korean Journal of Otorhinolaryngology-Head and Neck Surgery 66:5, pages 295-301.
Crossref
Crossref
Hongzhi Song, Chaoyi Yin, Zhuopeng Li, Ke Feng, Yangkun Cao, Yujie Gu & Huiyan Sun. (2023) Identification of Cancer Driver Genes by Integrating Multiomics Data with Graph Neural Networks. Metabolites 13:3, pages 339.
Crossref
Crossref
Sakshi Arora, Andrew M. Scott & Peter W. Janes. (2023) Eph Receptors in Cancer. Biomedicines 11:2, pages 315.
Crossref
Crossref
Junpeng Liu, Zewen Zhou, Yifan Jiang, Yuzhao Lin, Yunzhi Yang, Chongjiang Tian, Jinwen Liu, Hao Lin & Bin Huang. (2023) EPHA3 Could Be a Novel Prognosis Biomarker and Correlates with Immune Infiltrates in Bladder Cancer. Cancers 15:3, pages 621.
Crossref
Crossref
Jelte Kelchtermans & Hakon Hakonarson. (2022) The role of gene–ambient air pollution interactions in paediatric asthma. European Respiratory Review 31:166, pages 220094.
Crossref
Crossref
Jason Thomas Duskey, Arianna Rinaldi, Ilaria Ottonelli, Riccardo Caraffi, Chiara Alessia De Benedictis, Ann Katrin Sauer, Giovanni Tosi, Maria Angela Vandelli, Barbara Ruozi & Andreas Martin Grabrucker. (2022) Glioblastoma Multiforme Selective Nanomedicines for Improved Anti-Cancer Treatments. Pharmaceutics 14:7, pages 1450.
Crossref
Crossref
Rayan Berabez, Sylvain Routier, Hélène Bénédetti, Karen Plé & Béatrice Vallée. (2022) LIM Kinases, Promising but Reluctant Therapeutic Targets: Chemistry and Preclinical Validation In Vivo. Cells 11:13, pages 2090.
Crossref
Crossref
Eduardo de Paula Nascente, Renée Laufer Amorim, Carlos Eduardo Fonseca-Alves & Veridiana Maria Brianezi Dignani de Moura. (2022) Comparative Pathobiology of Canine and Human Prostate Cancer: State of the Art and Future Directions. Cancers 14:11, pages 2727.
Crossref
Crossref
Michael Wessolly, Elena Mairinger, Sabrina Borchert, Agnes Bankfalvi, Pawel Mach, Kurt Werner Schmid, Rainer Kimmig, Paul Buderath & Fabian Dominik Mairinger. (2022) CAF-Associated Paracrine Signaling Worsens Outcome and Potentially Contributes to Chemoresistance in Epithelial Ovarian Cancer. Frontiers in Oncology 12.
Crossref
Crossref
Ratnam S. Seelan, M. Michele Pisano & Robert M. Greene. (2022) MicroRNAs as epigenetic regulators of orofacial development. Differentiation 124, pages 1-16.
Crossref
Crossref
Kelly Karl, Taylor P. Light & Kalina Hristova. 2022. Comprehensive Pharmacology. Comprehensive Pharmacology
10
36
.
Yan Xu, Dorothea Robev, Nayanendu Saha, Bingcheng Wang, Matthew B. Dalva, Kai Xu, Juha P. Himanen & Dimitar B. Nikolov. (2021) The Ephb2 Receptor Uses Homotypic, Head-to-Tail Interactions within Its Ectodomain as an Autoinhibitory Control Mechanism. International Journal of Molecular Sciences 22:19, pages 10473.
Crossref
Crossref
Adriana C. Pliego Zamora, Hansini Ranasinghe, Jessica E. Lisle, Chun Ki Ng, Stephen Huang, Racheal Wadlow, Andrew M. Scott, Andrew W. Boyd & Christopher I. Slape. (2021) Cell-Extrinsic Differentiation Block Mediated by EphA3 in Pre-Leukaemic Thymus Contributes to Disease Progression. Cancers 13:15, pages 3858.
Crossref
Crossref
Takumi Itoh, Ryo Hatano, Yoshiya Horimoto, Taketo Yamada, Dan Song, Haruna Otsuka, Yuki Shirakawa, Shuji Mastuoka, Noriaki Iwao, Thomas M. Aune, Nam H. Dang, Yutaro Kaneko, Ko Okumura, Chikao Morimoto & Kei Ohnuma. (2021) IL-26 mediates epidermal growth factor receptor-tyrosine kinase inhibitor resistance through endoplasmic reticulum stress signaling pathway in triple-negative breast cancer cells. Cell Death & Disease 12:6.
Crossref
Crossref
Song-Hee Kim, Byung-Chul Kang, Daseul Seong, Won-Hyeok Lee, Jae-Hee An, Hyoung-Uk Je, Hee-Jeong Cha, Hyo-Won Chang, Sang-Yoon Kim, Seong-Who Kim & Myung-Woul Han. (2021) EPHA3 Contributes to Epigenetic Suppression of PTEN in Radioresistant Head and Neck Cancer. Biomolecules 11:4, pages 599.
Crossref
Crossref
Seungbeom Lee, Jisu Kim, Jeyun Jo, Jae Won Chang, Jaehoon Sim & Hwayoung Yun. (2021) Recent advances in development of hetero-bivalent kinase inhibitors. European Journal of Medicinal Chemistry 216, pages 113318.
Crossref
Crossref
Tatyana Alexandrovna Bogoyavlenskaya, Ekaterina Evgenyevna Tyagunova, Roman Konstantinovich Kostin, Alexander Sergeevich Zaharov, Yuriy Leonidovich Vasil'ev & Olesya Vasilevna Kytko. (2021) Glioblastoma Break-in; Try Something New. International Journal of Cancer Management 14:1.
Crossref
Crossref
Taylor P. Light, Christopher King & Kalina Hristova. 2021. Encyclopedia of Biological Chemistry III. Encyclopedia of Biological Chemistry III
766
779
.
Max London & Eugenio Gallo. (2020) The EphA2 and cancer connection: potential for immune-based interventions. Molecular Biology Reports 47:10, pages 8037-8048.
Crossref
Crossref
Max London & Eugenio Gallo. (2020) Critical role of EphA3 in cancer and current state of EphA3 drug therapeutics. Molecular Biology Reports 47:7, pages 5523-5533.
Crossref
Crossref
Peter W. Janes, Mary E. Vail, Hui K. Gan & Andrew M. Scott. (2020) Antibody Targeting of Eph Receptors in Cancer. Pharmaceuticals 13:5, pages 88.
Crossref
Crossref
Xinxin Chen, Lehong Zhang, Min Yuan, Ziqiao Kuang, Ying Zou, Tian Tang, Wangjian Zhang, Xiaowu Hu, Ting Xia, Tengfei Cao & Haixia Jia. (2020) Sam68 Promotes the Progression of Human Breast Cancer through inducing Activation of EphA3. Current Cancer Drug Targets 20:1, pages 76-83.
Crossref
Crossref
Franciele Aline Bruinsmann, Gustavo Richter Vaz, Aline de Cristo Soares Alves, Tanira Aguirre, Adriana Raffin Pohlmann, Silvia Stanisçuaski Guterres & Fabio Sonvico. (2019) Nasal Drug Delivery of Anticancer Drugs for the Treatment of Glioblastoma: Preclinical and Clinical Trials. Molecules 24:23, pages 4312.
Crossref
Crossref
Xiuzhi Duan, Xiaoming Xu, Binbin Yin, Bong Hong, Weiwei Liu, Qian Liu & Zhihua Tao. (2019) The prognosis value of EphA3 and the androgen receptor in prostate cancer treated with radical prostatectomy. Journal of Clinical Laboratory Analysis 33:5.
Crossref
Crossref
Christin Lund-Andersen, Sigve Nakken, Ståle Nygård, Bastian Fromm, Lars B. Aasheim, Ben Davidson, Lars Julsrud, Torveig W. Abrahamsen, Annette T. Kristensen, Brit Dybdahl, Stein G. Larsen, Eivind Hovig & Kjersti Flatmark. (2019) Integrative genomic analysis of peritoneal malignant mesothelioma: understanding a case with extraordinary chemotherapy response. Molecular Case Studies 5:2, pages a003566.
Crossref
Crossref
Roberto Ria, Antonio Solimando, Assunta Melaccio, Azzurra Sportelli & Angelo Vacca. 2019. Update on Multiple Myeloma. Update on Multiple Myeloma.
Carolin Offenhäuser, Fares Al-Ejeh, Simon Puttick, Kathleen Ensbey, Zara Bruce, Paul Jamieson, Fiona Smith, Brett Stringer, Benjamin Carrington, Adrian Fuchs, Craig Bell, Rosalind Jeffree, Stephen Rose, Kristofer Thurecht, Andrew Boyd & Bryan Day. (2018) EphA3 Pay-Loaded Antibody Therapeutics for the Treatment of Glioblastoma. Cancers 10:12, pages 519.
Crossref
Crossref
Nayanendu Saha, Dorothea Robev, Emilia O. Mason, Juha P. Himanen & Dimitar B. Nikolov. (2018) Therapeutic potential of targeting the Eph/ephrin signaling complex. The International Journal of Biochemistry & Cell Biology 105, pages 123-133.
Crossref
Crossref
Xia Chen, Bin Lu, Qian Ma, Cheng‑Dong Ji & Jian‑Zhong Li. (2018) EphA3 inhibits migration and invasion of esophageal cancer cells by activating the mesenchymal‑epithelial transition process. International Journal of Oncology.
Crossref
Crossref
Renji ChenSiyuan GuoXin WangYue MuErling DuanYi Xu. (2018)
Association of
EPHA3
Gene Polymorphisms with Nonsyndromic Cleft Lip With or Without Cleft Palate
. Genetic Testing and Molecular Biomarkers 22:7, pages 420-424.
Crossref
Crossref
Song Hee Kim, Won Hyeok Lee, Seong Who Kim, Hyoung Uk Je, Jong Cheol Lee, Hyo Won Chang, Young Min Kim, Kyungbin Kim, Sang Yoon Kim & Myung Woul Han. (2018) EphA3 maintains radioresistance in head and neck cancers through epithelial mesenchymal transition. Cellular Signalling 47, pages 122-130.
Crossref
Crossref
Sergey Malchenko, Simone T. Sredni, Jerusha Boyineni, Yingtao Bi, Naira V. Margaryan, Maheedhara R. Guda, Yulia Kostenko, Tadanori Tomita, Ramana V. Davuluri, Kiran Velpula, Mary J.C. Hendrix & Marcelo B. Soares. (2018) Characterization of brain tumor initiating cells isolated from an animal model of CNS primitive neuroectodermal tumors. Oncotarget 9:17, pages 13733-13747.
Crossref
Crossref
Samanth Reddy Kedika & D. Gomika Udugamasooriya. (2018) Converting a weaker ATP-binding site inhibitor into a potent hetero-bivalent ligand by tethering to a unique peptide sequence derived from the same kinase. Organic & Biomolecular Chemistry 16:35, pages 6443-6449.
Crossref
Crossref
Corinna Köhler, David Nittner, Florian Rambow, Enrico Radaelli, Fabio Stanchi, Niels Vandamme, Arianna Baggiolini, Lukas Sommer, Geert Berx, Joost J. van den Oord, Holger Gerhardt, Cedric Blanpain & Jean-Christophe Marine. (2017) Mouse Cutaneous Melanoma Induced by Mutant BRaf Arises from Expansion and Dedifferentiation of Mature Pigmented Melanocytes. Cell Stem Cell 21:5, pages 679-693.e6.
Crossref
Crossref
Antonella Caivano, Francesco La Rocca, Ilaria Laurenzana, Tiziana Annese, Roberto Tamma, Ubaldo Famigliari, Vittorio Simeon, Stefania Trino, Luciana De Luca, Oreste Villani, Simona Berardi, Antonio Basile, Angelo Vacca, Giuseppe Saglio, Luigi Del Vecchio, Pellegrino Musto & Daniela Cilloni. (2017) Epha3 acts as proangiogenic factor in multiple myeloma. Oncotarget 8:21, pages 34298-34309.
Crossref
Crossref
Xiaoqin Liu, Yunzhao Xu, Qin Jin, Wei Wang, Shu Zhang, Xudong Wang, Yuquan Zhang, Xujuan Xu & Jianfei Huang. (2016) EphA8 is a prognostic marker for epithelial ovarian cancer. Oncotarget 7:15, pages 20801-20809.
Crossref
Crossref
G. Hood, R. Laufer-Amorim, C.E. Fonseca-Alves & C. Palmieri. (2016) Overexpression of Ephrin A3 Receptor in Canine Prostatic Carcinoma. Journal of Comparative Pathology 154:2-3, pages 180-185.
Crossref
Crossref
Thao M. Nguyen, Agnieszka Arthur & Stan Gronthos. (2015) The role of Eph/ephrin molecules in stromal–hematopoietic interactions. International Journal of Hematology 103:2, pages 145-154.
Crossref
Crossref
M. Mansour, E. Nievergall, K. Gegenbauer, C. Llerena, L. Atapattu, M. Halle, M. L. Tremblay, P. W. Janes & M. Lackmann. (2015) PTP-PEST controls EphA3 activation and ephrin-induced cytoskeletal remodelling. Journal of Cell Science 129:2, pages 277-289.
Crossref
Crossref
Deo R. SinghQingQing CaoChristopher KingMatt SalottoFozia AhmedXiang Yang ZhouElena B. PasqualeKalina Hristova. (2015) Unliganded EphA3 dimerization promoted by the SAM domain. Biochemical Journal 471:1, pages 101-109.
Crossref
Crossref
Garry Jason Forse, Maria Loressa Uson, Fariborz Nasertorabi, Anand Kolatkar, Ilaria Lamberto, Elena Bianca Pasquale & Peter Kuhn. (2015) Distinctive Structure of the EphA3/Ephrin-A5 Complex Reveals a Dual Mode of Eph Receptor Interaction for Ephrin-A5. PLOS ONE 10:5, pages e0127081.
Crossref
Crossref